Cytomel (Liothyronine) Cost in Maryland 2026: Cash Price, Insurance, Medicaid & Savings

What Liothyronine Actually Costs at Maryland Pharmacies in 2026

The average cash price for generic liothyronine across Maryland retail pharmacies in 2026 sits at approximately $35 per month for a standard 30-tablet supply. Brand-name Cytomel, manufactured by Pfizer, carries a list price near $120 per month, though very few patients pay this figure out of pocket.

Price variation across the state is real and sometimes dramatic. A CVS or Walgreens in Baltimore may charge $28 for a 30-day supply of generic liothyronine 25 mcg, while an independent pharmacy in Western Maryland might price the same quantity at $45. Checking multiple pharmacies before filling is worth the effort. Discount platforms like GoodRx can push prices below $15 at select chains 1.

Liothyronine is a synthetic form of triiodothyronine (T3), approved by the FDA for the treatment of hypothyroidism, myxedema coma, and as a diagnostic agent in thyroid suppression tests 2. The American Thyroid Association (ATA) 2014 guidelines acknowledge T3 combination therapy as an option when patients report persistent symptoms on levothyroxine monotherapy, noting that "a trial of combination LT4/LT3 therapy can be considered" in specific clinical scenarios 3. This guideline context matters because insurance coverage decisions in Maryland often hinge on whether a prescriber can document clinical necessity consistent with published recommendations.

The Bunevicius et al. study published in the New England Journal of Medicine in 1999 was one of the first randomized controlled trials to demonstrate that substituting a portion of levothyroxine with liothyronine improved cognitive function, mood, and physical symptom scores in 33 patients with hypothyroidism 4. That trial remains a touchstone in the T3 therapy debate, even as subsequent larger trials have produced mixed results.

Generic vs. Brand Cytomel: Where the Savings Are

Choosing generic liothyronine over brand Cytomel saves Maryland patients roughly $85 per month at list price. Generic is the default at most pharmacies unless a prescriber writes "dispense as written."

Generic liothyronine tablets are manufactured by several companies, including Mylan, Sigmapharm, and Hikma. The FDA considers these bioequivalent to brand Cytomel, meaning they deliver the same amount of active T3 within acceptable pharmacokinetic ranges 5. Some thyroid patients and endocrinologists have raised concerns about lot-to-lot variability in narrow therapeutic index drugs. The ATA has acknowledged these concerns but has not issued a blanket recommendation against generics.

For patients who experience symptom fluctuations when switching between manufacturers, asking the pharmacy to source from the same generic manufacturer each refill can help. Maryland pharmacies are not required by state law to dispense a specific generic, but most will accommodate consistent sourcing on request.

Compounded liothyronine from a licensed 503A pharmacy in Maryland typically runs about $40 per month. Compounded formulations offer the advantage of custom dosing (for example, 2.5 mcg or 7.5 mcg, doses not available in commercial tablets) and sustained-release capsules. However, compounded medications are not FDA-approved products, so insurance plans rarely cover them 6.

Maryland Medicaid Coverage for Liothyronine

Maryland Medicaid covers liothyronine, but it requires prior authorization (PA). This means the prescribing clinician must submit documentation showing why the patient needs T3 in addition to, or instead of, standard levothyroxine therapy.

The PA process typically requires evidence that the patient has tried levothyroxine monotherapy, that TSH and free T4 levels are within reference ranges, and that the patient continues to experience symptoms consistent with hypothyroidism. A 2018 analysis in Thyroid found that approximately 15% of hypothyroid patients report residual symptoms despite optimized levothyroxine therapy (N=691) 7. Documenting these persistent symptoms strengthens the PA submission.

Maryland Medicaid generally covers generic liothyronine rather than brand Cytomel. The turnaround for PA approval ranges from 24 to 72 hours for standard requests, with expedited review available in urgent situations. If a PA is denied, patients and prescribers can appeal through Maryland's Fair Hearing process. Dr. Antonio Bianco, a professor of medicine at the University of Chicago and leading T3 researcher, has stated: "There is a subgroup of hypothyroid patients who do benefit from T3, and denying access based purely on cost creates a clinical disservice" 8.

For patients who are dually eligible for Medicare and Medicaid, Part D plans may also cover generic liothyronine with their own formulary restrictions. Checking both programs for the most favorable terms is advisable.

Insurance Coverage Across Maryland Plans

Most major commercial insurers operating in Maryland place generic liothyronine on Tier 1 or Tier 2 of their formularies. Brand Cytomel, when covered at all, usually lands on Tier 3 or requires step therapy through a generic first.

CareFirst BlueCross BlueShield, the largest insurer in Maryland, covers generic liothyronine with standard copays ranging from $5 to $20 per month for most plan levels. Kaiser Permanente Mid-Atlantic and UnitedHealthcare plans available through the Maryland Health Benefit Exchange also cover generic liothyronine, though formulary placement varies by plan year 9.

Step therapy is common. Many Maryland plans require documented treatment with levothyroxine for at least 90 days before approving liothyronine. The clinical rationale aligns with ATA guidelines, which recommend levothyroxine as first-line therapy for hypothyroidism 3.

Patients whose plans deny coverage for liothyronine have several options. Internal appeals, external review through the Maryland Insurance Administration, and manufacturer assistance programs can all reduce out-of-pocket burden. The Pfizer patient assistance program may cover brand Cytomel for uninsured or underinsured patients who meet income eligibility criteria 10.

How the Pfizer Savings Card and Generic Discount Programs Work

Pfizer offers a copay savings card for brand Cytomel that can reduce out-of-pocket costs to as little as $0 for commercially insured patients. The card typically covers up to a set dollar amount per prescription fill and is not valid for patients on government insurance (Medicaid, Medicare, TRICARE).

To use the Pfizer savings card, patients register online or receive a card through their prescriber. The card is presented at the pharmacy alongside the insurance card. It functions as a secondary payer, covering the difference between the insurance copay and the program's maximum benefit. Eligibility usually resets annually.

For generic liothyronine, GoodRx, RxSaver, and SingleCare offer free discount coupons that work at most Maryland chain pharmacies. These coupons are not insurance. They represent pre-negotiated rates between the coupon platform and the pharmacy benefit manager. In Baltimore, GoodRx prices for 30 tablets of generic liothyronine 25 mcg have been reported as low as $9.47 at select locations 11.

Costco and Walmart pharmacy discount programs also deserve mention. Costco does not require a membership to use its pharmacy in Maryland, and its cash prices for generic liothyronine are often among the lowest in the state. Walmart's $4 generic program does not include liothyronine, but its cash prices remain competitive.

For patients without any insurance, Maryland's Health Services Cost Review Commission (HSCRC) does not regulate outpatient pharmacy pricing directly. However, some hospital-based outpatient pharmacies offer sliding-scale pricing for qualifying patients.

Compounded Liothyronine T3 in Maryland: Legality and Access

Compounded liothyronine is legal in Maryland through licensed 503A pharmacies. A 503A pharmacy compounds medications pursuant to a valid, patient-specific prescription from a licensed prescriber 6. Maryland does not impose additional state-level restrictions on T3 compounding beyond federal requirements.

Several compounding pharmacies in Maryland prepare liothyronine in both immediate-release and sustained-release formulations. Sustained-release T3 is favored by some prescribers who want to avoid the serum T3 spikes associated with immediate-release dosing. A pharmacokinetic study by Jonklaas et al. demonstrated that immediate-release liothyronine produces peak T3 levels within 2 to 4 hours of administration, with levels returning to baseline by 8 to 12 hours 12.

The cost for compounded liothyronine in Maryland averages $40 per month, though prices vary by pharmacy, dose, and formulation type. Because compounded drugs are not FDA-approved, insurance coverage is the exception rather than the rule. Patients should confirm that the compounding pharmacy is accredited by the Pharmacy Compounding Accreditation Board (PCAB) or holds equivalent quality certifications.

503B outsourcing facilities can also supply liothyronine to Maryland healthcare facilities, but these are not patient-facing pharmacies. They produce compounded drugs in bulk without patient-specific prescriptions and are subject to FDA oversight similar to manufacturers.

Telehealth Prescribing of Liothyronine in Maryland

Maryland permits telehealth prescribing of liothyronine. The Maryland Board of Physicians allows licensed clinicians to prescribe medications through audio-visual telehealth encounters, and this authority extends to thyroid medications including T3.

Patients seeking liothyronine via telehealth should ensure the prescribing clinician holds a valid Maryland medical license (or equivalent compact state license) and that the telehealth platform conducts a proper evaluation, including review of thyroid labs. The 2024 ATA position statement on telemedicine for thyroid disease management endorsed telehealth as an appropriate modality for ongoing thyroid hormone management, provided that laboratory monitoring continues at recommended intervals 13.

Typical telehealth visit costs in Maryland range from $50 to $150 for an initial thyroid consultation, with follow-ups often priced between $30 and $75. Some telehealth platforms include lab orders in their pricing. HealthRX offers telehealth evaluation for thyroid patients who may benefit from T3 therapy.

After a telehealth visit, the prescription can be sent electronically to any Maryland pharmacy, including compounding pharmacies. Controlled substance restrictions do not apply to liothyronine, as it is not a scheduled drug under federal or Maryland law.

How to Get the Lowest Price on Liothyronine in Maryland

Start with the generic. At $35 per month average cash price, generic liothyronine is already affordable, but prices can drop below $10 with a discount coupon.

A practical step-by-step approach:

1. Ask your prescriber to write for generic liothyronine (not brand Cytomel) unless there is a clinical reason to specify brand.
2. Check GoodRx, RxSaver, or SingleCare for the lowest coupon price at pharmacies near you.
3. Compare cash prices at Costco, which does not require a membership for pharmacy services in Maryland.
4. If you have insurance, verify that generic liothyronine is on your plan's formulary and ask about tier placement.
5. If Medicaid covers your prescriptions, work with your prescriber to complete the prior authorization. Keep copies of all lab results and symptom documentation.
6. If you need a custom dose, request a quote from a licensed Maryland 503A compounding pharmacy. Expect to pay approximately $40 per month.
7. If brand Cytomel is medically necessary, apply for the Pfizer copay savings card to offset costs.

The European Thyroid Association's 2012 statement, authored by Wiersinga et al., noted that "the use of LT3 may be warranted in selected patients who have persistent complaints despite adequate LT4 therapy" 14. For Maryland patients who meet this clinical profile, the cost of T3 therapy should not be the barrier. Between generics, discount programs, Medicaid PA pathways, and compounding options, out-of-pocket costs can remain under $15 per month with proper navigation.

Maryland patients filling liothyronine for the first time should have TSH, free T4, and free T3 measured at baseline and again 6 to 8 weeks after starting therapy, per standard endocrine monitoring protocols 3.